PerkinElmer Inc. buy melinda
Start price
01.11.17
/
50%
€65.58
Target price
22.01.18
€76.67
Performance (%)
11.60%
End price
22.01.18
€73.13
Summary
This prediction ended on 22.01.18 with a price of €73.13. The BUY prediction by melinda finished with a performance of 11.60%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| PerkinElmer Inc. | 0.275% | 0.275% | -19.916% | -14.037% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by melinda for this prediction
In the thread PerkinElmer Inc. diskutieren
SecteurEquipement und fortschrittliche Medizintechnik
Daten aus Phase - II - Studien zur Gründung der Wirksamkeit der Behandlung der Kinder Nabelschnurblut gegen Zerebralparese
31. Oktober (Reuters) - Perkinelmer Inc: Daten aus Phase - II - Studien zur Gründung der Wirksamkeit der eigenen Nabelschnurblut des Kindes mit Zerebralparese zu behandeln.
(Vom Mitglied beendet)
Stopped prediction by melinda for PerkinElmer Inc.
PerkinElmer Inc.
Start price
Target price
Perf. (%)
€105.00
20.10.20
20.10.20
€110.00
04.11.21
04.11.21
40.76%
05.11.21
05.11.21
